Diffuse Cutaneous Scleroderma (DSSc) SFDI Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study — Stella

Home/Systemic Scleroderma/

View on ClinicalTrials.gov

Recruiting

Back to Systemic Scleroderma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Shapiro Outpatient Rheumatology Clinic at Boston Medical Center, Boston, Massachusetts

Key details

Sponsor

Boston University

Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Enrollment target

~65 participants

Started

November 2025

Primary completion

December 2028

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.